Production of protein array for serum antibody screening
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3P30CA060553-25S5
Grant search
Key facts
Disease
COVID-19Start & end year
19972023Known Financial Commitments (USD)
$395,000Funder
National Institutes of Health (NIH)Principal Investigator
Leonidas C PlataniasResearch Location
United States of AmericaLead Research Institution
Northwestern University At ChicagoResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
We propose to purify SARS-CoV-2 proteins to build a plate or filter-based array for rapid assessment of antibody responses. Proteins will be expressed in E. coli and purified as recombinant proteins. The arrays will initially be constructed manually using a vacuum blot system or ELISA plates. If arrays prove useful, a robotic system will be retooled. In addition to proteins already under study, we would expand our library to include all of the smaller open reading frames, especially proteins E and M, which are 100% conserved with SARS. The SARS-CoV-2 proteome can be covered in a 30 protein array. These arrays would then be used to ask novel questions about the development of the immune response in different patient cohorts, including cancer patients.